Answers are grounded in this paper and cite their sources.
We have previously shown that basic fibroblast growth factor (bFGF; 2 microg), when administered in gelfoams implanted to medullectomized adult rat adrenal glands, maintains target-deprived preganglionic neurons located in the intermediolateral column (IML) of the spinal cord. We show now that administration of 600 or 60 ng/implant/organ of the biologically active recombinant protein also maintains IML-neurons. The effects depend on an intact organ nerve supply since administration of bFGF-implants to the medullectomized and denervated (splanchnicotomized) organ abolishes the maintenance effects for IML-neurons. A possible regeneration of cholinergic nerve fibres was assessed by quantitative determination of choline acetyltransferase (ChAT)-activity and ultrastructurally under various treatments. When compared to a cytochrome-(Cyto)-C treatment, bFGF significantly increased ChAT-activity in the innervated adrenal gland after 4 weeks, suggesting that sprouting of cholinergic nerve fibres and/or recovery of enzyme activity had occurred. Electron microscopically, unmyelinated axons associated with Schwann cells were only found in bFGF, but not in Cyto-C-implants. We conclude that exogenous bFGF or a yet unidentified trophic molecule possibly induced by bFGF in the adrenal gland acts as a retrogradely transported messenger serving for the maintenance of spinal cord IML-neurons in vivo. By stimulating axonal sprouting, bFGF might facilitate access of trophic material to nerve fibres.
No takes yet. Share an insight, caveat, or question.
Blottner et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: